Schematic illustration of the composition and structural engineering of metal-based nanomaterials as LDI-MS matrices for detecting small-molecule biomarker in CAD and HF. (IMAGE)

Shanghai Jiao Tong University Journal Center

Schematic illustration of the composition and structural engineering of metal-based nanomaterials as LDI-MS matrices for detecting small-molecule biomarker in CAD and HF.

Caption

ig. 1 Schematic illustration of the composition and structural engineering of metal-based nanomaterials as LDI-MS matrices for detecting small-molecule biomarkers in coronary artery disease (CAD) and heart failure (HF). The design strategies encompass compositional tuning (single- and multi-component systems) and structural control (porous, core-shell, and array architectures), which together enable metabolic fingerprinting for diagnosis and subtyping of CAD and HF.

Ag: silver; Au: gold; Pd: palladium; Pt: platinum; Fe3O4: magnetite (iron oxide); Cu2O: cuprous oxide; ZnO: zinc oxide; TiO2: titanium dioxide; MOF: metal-organic framework; CAD: coronary artery disease; HF: heart failure

Credit

Li Ma, Jiao Wu, Jun Pu, Yida Huang, Kun Qian.

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.